ACRS · Aclaris Therapeutics, Inc. · Documents
Market Cap
$783.10M
Shares
147.20M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-08-06 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-06-04 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-04-28 | — | |
| DEF 14A | 2026-04-23 | 2026-06-04 | |
| Investor Event Transcript | 2026-04-14 | 2026-06-30 | |
| 8-K | 2026-03-11 | 2026-03-10 | |
| 8-K | 2026-03-10 | 2026-03-09 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-29 | — | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-05 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-24 | 2025-06-05 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-18 | 2024-11-16 | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-07-16 | — | |
| 8-K | 2024-06-07 | 2024-06-06 | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-25 | 2024-06-06 | |
| 8-K | 2024-03-19 | 2024-03-14 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-02-05 | 2024-01-31 | |
| 8-K/A | 2024-02-05 | 2024-01-15 | |
| 8-K | 2024-01-19 | 2024-01-15 | |
| 8-K | 2023-12-19 | — | |
| 8-K | 2023-11-13 | — | |
| 8-K | 2023-11-06 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 |
Showing 1–50 of 123 filings
Key facts
CIK
1557746
CUSIP
00461U105
13F (30d)
79 filings
79 filers
Visit website
Investor relations